Daiichi Sankyo Subsidiary Applies for Additional Indication for Fentanyl Injection.Tokyo, Japan, Oct 2, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Sankyo Co., Ltd., a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Daiichi Sankyo Company, Limited, has filed an application for an additional indication for Fentanyl fentanyl /fen·ta·nyl/ (fen´tah-nil) an opioid analgesic; the citrate salt is used as an adjunct to anesthesia, in the induction and maintenance of anesthesia, in combination with droperidol (or similar agent) as a neuroleptanalgesic, and Injection 0.1 mg and 0.25 mg (generic name generic name n. 1. The official nonproprietary name of a drug, under which it is licensed and identified by the manufacturer. 2. : fentanyl citrate) with the Ministry of Health, Labour and Welfare. Fentanyl Injection is widely used in analgesia analgesia /an·al·ge·sia/ (an?al-je´ze-ah) 1. absence of sensibility to pain. 2. the relief of pain without loss of consciousness. and sedation, as well as in anesthesia and as an anesthetic adjunct, but its use has been contraindicated in Japan for pediatric patients aged two and under because its safety in this group had not been established. However, driven by a need in this area, a physician-led Phase III trial was conducted in pediatric patients. The trial, which included newborns and infants, generated valuable information about a patient group that is generally excluded from surgical clinical studies. On the basis of the results, Sankyo filed for the additional indication in pediatric patients, including infants aged two and under. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion